Laurus Labs informs about press release

22 Jul 2019 Evaluate

Laurus Labs has informed about the launch of the generic version of Lyrica®, (pregabalin) Capsules, in all eight commercially available strengths (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, & 300 mg) in US market along with its exclusive distribution partner Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company. Rising recently received the final approval from the US Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA). A press release to this extent is also attached. 

\The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

1037.30 16.40 (1.61%)
10-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1313.90
Cipla 1333.10
Zydus Lifesciences 922.90
Lupin 2340.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×